Marcos Malumbres

Active 1998–2025

93
Papers
27,346
Citations
74
h-index
89
i10-index

Citations

Citations per year for Marcos Malumbres1980: 1 citations1996: 1 citations1998: 2 citations1999: 7 citations2000: 12 citations2001: 24 citations2002: 48 citations2003: 94 citations2004: 133 citations2005: 154 citations2006: 152 citations2007: 162 citations2008: 180 citations2009: 283 citations2010: 267 citations2011: 277 citations2012: 302 citations2013: 268 citations2014: 272 citations2015: 282 citations2016: 230 citations2017: 297 citations2018: 327 citations2019: 921 citations2020: 1,116 citations2021: 1,009 citations2022: 785 citations2023: 546 citations2024: 789 citations2025: 368 citations2026: 15 citations1981–1995: no citations, so these years are not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,704 citing papers, 24.8% of this breakdownChina: 1,855 citing papers, 17% of this breakdownUnited Kingdom: 710 citing papers, 6.5% of this breakdownSpain: 523 citing papers, 4.8% of this breakdownGermany: 499 citing papers, 4.6% of this breakdownFrance: 394 citing papers, 3.6% of this breakdownItaly: 385 citing papers, 3.5% of this breakdownCanada: 289 citing papers, 2.7% of this breakdownJapan: 280 citing papers, 2.6% of this breakdownIndia: 265 citing papers, 2.4% of this breakdownAustralia: 209 citing papers, 1.9% of this breakdownSouth Korea: 207 citing papers, 1.9% of this breakdown
0%24.8%Other 23.7%

Fields

  • Biochemistry, Genetics and Molecular Biology52.2%
  • Medicine39.1%
  • Immunology and Microbiology2.3%
  • Computer Science1.2%
  • Neuroscience1.2%
  • Agricultural and Biological Sciences1.2%
  • Other2.8%

Topics

  • Cancer-related Molecular Pathways7.5%
  • Microtubule and mitosis dynamics4.9%
  • Advanced Breast Cancer Therapies3%
  • Ubiquitin and proteasome pathways3%
  • Epigenetics and DNA Methylation2.7%
  • MicroRNA in disease regulation2.4%
  • Other76.5%

Coauthors

All papers

Open in search
  1. Cell cycle, CDKs and cancer: a changing paradigm

    Authors: , - Nature reviews. Cancer 2009 cited by 3,935

  2. Cyclin-dependent kinases

    Authors: - Genome biology 2014 cited by 1,678

  3. RAS oncogenes: the first 30 years

    Authors: , - Nature reviews. Cancer 2003 cited by 1,878

  4. Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition

    Authors: , - Cancer Cell 2020 cited by 394

  5. Programmed mitophagy is essential for the glycolytic switch during cell differentiation

    Authors: , , , , , , , , , , , , , - The EMBO Journal 2017 cited by 331

  6. Cdk1 is sufficient to drive the mammalian cell cycle

    Authors: , , , , , , , , , - Nature 2007 cited by 1,109

  7. Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases

    Authors: , , - Nature Reviews Molecular Cell Biology 2016 cited by 538

  8. To cycle or not to cycle: a critical decision in cancer

    Authors: , - Nature reviews. Cancer 2001 cited by 1,470

  9. Mammalian Cells Cycle without the D-Type Cyclin-Dependent Kinases Cdk4 and Cdk6

    Authors: , , , , , , , - Cell 2004 cited by 790

  10. Mammalian cyclin-dependent kinases

    Authors: , - Trends in Biochemical Sciences 2005 cited by 1,290

  11. The cell proliferation antigen Ki-67 organises heterochromatin

    Authors: , , , , , , , , , , , , , , , , , , , , - eLife 2016 cited by 381

  12. Mammalian cell cycle cyclins

    Authors: , - Seminars in Cell and Developmental Biology 2020 cited by 182

  13. Cyclin-dependent kinases: a family portrait

    Authors: , , , , , , , , - Nature Cell Biology 2009 cited by 499

  14. A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2013 cited by 312

  15. CDK6 as a key regulator of hematopoietic and leukemic stem cell activation

    Authors: , , , , , , , , , , , , - Blood 2014 cited by 279

  16. CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma

    Authors: , , , , , , , , , , , - Cancer Cell 2020 cited by 180

  17. HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5

    Authors: , , , , , , , , , , , , , , , , , , - Molecular Cell 2012 cited by 203

  18. A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy

    Authors: , , , , , , , , , , , , , - Oncotarget 2015 cited by 161

  19. Fueling the Cell Division Cycle

    Authors: , - Trends in Cell Biology 2016 cited by 288

  20. AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest

    Authors: , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2015 cited by 277

  21. Plk1 overexpression induces chromosomal instability and suppresses tumor development

    Authors: , , , , , , , , , , , , - Nature Communications 2018 cited by 166

  22. International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maja V. Maraldo, Gustavo Nader Marta, Ingvil Mjaaland, Gilberto Morgan, Barbara Pistilli, Shani Paluch–Shimon, Sofía Rivera, Sven Rottenberg, Cristina Saura, Tanja Skyttä, Tanja Španić - The Lancet Oncology 2024 cited by 77

  23. MicroRNAs and the cell cycle

    Authors: , - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011 cited by 419

  24. From Plk1 to Plk5

    Authors: , , - Cell Cycle 2011 cited by 275